Moderated by Sarah Bauerle Bass, associate professor in the Department of Social and Behavioral Sciences and director of the Risk Communication Laboratory, and panelists:
- Silvana Mazzella, SSW '00, associate executive director for Prevention Point
- Paolo D. del Vecchio, BSW '85, MSW '86, director of the Office of Management, Technology, and Operations for the Substance Abuse and Mental Health Services Administration (SAMHSA) within the U.S. Department of Health and Human Services.
- Christopher M. Barnett, JD, CLA ’10, chief executive officer of ICBD Holdings and founding partner for GateHouse Treatment
- Sam MacMaster, chief science officer for GateHouse Treatment and adjunct associate professor at Baylor College of Medicine in Houston, Texas.
Topics include:
- Impact of COVID-19 on people who use drugs
- Regulatory changes
- Practicing Harm Reduction in the COVID-19 Outbreak
- Unique challenges to people with substance use disorder regarding transmission of the virus that causes COVID-19
- The new normal among substance use treatment providers: Impact of COVID on access to treatment and essential services
- Impact of COVID-19, quarantine, and the economic changes on problematic substance use as we move forward
Join the session on May 13: https://temple.zoom.us/j/91917361293